[1]
Tun, K.D. et al. 2021. Assessment of the immunoexpression profile of breast ductal carcinoma with Cyclin D1, Her-2/Neu and p53 at Yangon General Hospital, Myanmar. Nepalese Journal of Cancer. 5, 1 (Sep. 2021), 44–49. DOI:https://doi.org/10.3126/njc.v5i1.41403.